Last reviewed · How we verify

NCT05655611

Muscle Energy Technique With Or Without First Rib Mobilization In Adhesive Capsulitis

Completed NA Last updated 16 March 2023
What this trial tests

NA trial testing first rib mobilization in Adhesive Capsulitis in 40 participants. Completed in 7 March 2023.

Timeline
10 October 2022
Primary endpoint
7 March 2023
7 March 2023

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date10 October 2022
Primary completion7 March 2023
Estimated completion7 March 2023
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 40 to 70, any sex, with Adhesive Capsulitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be a randomized control trial. Study will be conducted in 40 patients in the age range 40-70 years, which will be selected by using non proability convenient sampling technique. Subjects will be divided in 2 groups. Group A will receive first rib mobilization along with METS and conventional treatment, group B will receive METS and conventional physical therapy treatment only. Treatment will be given thrice per week for 3 weeks. Data will be collected pre and post treatment, for data collection numeric pain rating scale, shoulder pain and disability index (SPADI) will be used. Joint range of motion will be measured using goniometer. After collection data from defined study setting, data will be entered and analyzed at Riphah International University, Lahore.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Adhesive Capsulitis

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05655611.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing